DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C1332979 | Childhood Lymphoma | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C1292754 | Mediastinal (Thymic) Large B-Cell Lymphoma | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0206062 | Lung Diseases, Interstitial | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0021390 | Inflammatory Bowel Diseases | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0011615 | Dermatitis, Atopic | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0220597 | Adult Hodgkin Lymphoma | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0086438 | Hypogammaglobulinemia | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0023486 | Prolymphocytic Leukemia | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C1334657 | Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma | FCER2 | 2208 | Fc fragment of IgE receptor II | P06734 |
C0003864 | Arthritis | ENO1 | 2023 | enolase 1 | P06733 |
C0205643 | Carcinoma, Cribriform | ENO1 | 2023 | enolase 1 | P06733 |
C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | ENO1 | 2023 | enolase 1 | P06733 |
C0017665 | Membranous glomerulonephritis | ENO1 | 2023 | enolase 1 | P06733 |
C1306459 | Primary malignant neoplasm | ENO1 | 2023 | enolase 1 | P06733 |
C0017638 | Glioma | ENO1 | 2023 | enolase 1 | P06733 |
C0024141 | Lupus Erythematosus, Systemic | ENO1 | 2023 | enolase 1 | P06733 |
C0029408 | Degenerative polyarthritis | ENO1 | 2023 | enolase 1 | P06733 |
C0476089 | Endometrial Carcinoma | ENO1 | 2023 | enolase 1 | P06733 |
C0027651 | Neoplasms | ENO1 | 2023 | enolase 1 | P06733 |
C1458155 | Mammary Neoplasms | ENO1 | 2023 | enolase 1 | P06733 |
C0041296 | Tuberculosis | ENO1 | 2023 | enolase 1 | P06733 |
C2239176 | Liver carcinoma | ENO1 | 2023 | enolase 1 | P06733 |
C0003873 | Rheumatoid Arthritis | ENO1 | 2023 | enolase 1 | P06733 |
C0205641 | Adenocarcinoma, Basal Cell | ENO1 | 2023 | enolase 1 | P06733 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024